To collect data on cancer treatment, its outcome and epidemiology in pregnant patient having breast cancer
Not Applicable
- Conditions
- Health Condition 1: null- Patients having Pregnancy associated breast cancer
- Registration Number
- CTRI/2017/02/007907
- Lead Sponsor
- Roche Products India Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Patients with histological confirmed breast cancer who are pregnant
Or Patients who got diagnosed within 1 year of last pregnancy with histological confirmed breast cancer
Informed consent for data collection (for prospective participants only)
For retrospective participants an informed consent is not required as long as the data are anonymously captured
Exclusion Criteria
Unwilling to participate
Not able to give valid informed consent
In retrospective registry where records not available
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Stage and biological characteristics of breast cancer <br/ ><br>Breast cancer therapy <br/ ><br>Sensitivity and specificity of diagnostic procedures palpation USG mammogram <br/ ><br>Adverse events/side effects in PABC patients receiving chemotherapy compared to non-pregnant young women receiving chemotherapy <br/ ><br>Outcome of the newborn after therapy <br/ ><br>Outcome of breast cancer after diagnosis <br/ ><br>Rate of pregnancies after breast cancer <br/ ><br>Timepoint: Observational Trial,data will be assessed post completion of target accrual.
- Secondary Outcome Measures
Name Time Method Observational Trial, for assessing on epidemiology and treatment patterns and outcomes of PABCTimepoint: Data will be assessed post completion of target accrual.;Stage and biological characteristics of breast cancer <br/ ><br>Breast cancer therapy <br/ ><br>Sensitivity and specificity of diagnostic procedures palpation USG mammogram <br/ ><br>Adverse events/side effects in PABC patients receiving chemotherapy compared to non-pregnant young women receiving chemotherapy <br/ ><br>Outcome of the newborn after therapy <br/ ><br>Outcome of breast cancer after diagnosis <br/ ><br>Rate of pregnancies after breast cancer <br/ ><br>Timepoint: Not applicable as its observational study both prospective and retroprospective